BIOSPECIFICS TECHNOLOGIES CORP·4

Sep 18, 6:14 PM ET

Morgan Henry 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Sep 18, 2012

Insider Transaction Report

Form 4
Period: 2012-09-14
Morgan Henry
Director
Transactions
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2012-09-14$1.00/sh+5,425$5,42537,193 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2012-09-145,4250 total
    Exercise: $1.00From: 2003-09-30Exp: 2012-09-30Common Stock, $0.001 par value (5,425 underlying)

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES